Literature DB >> 32257758

A case of chest wall recurrence of hilar cholangiocarcinoma 10 years after R1 surgery with positive ductal margin of carcinoma in situ.

Chisho Mitsuura1, Hirohisa Okabe1, Yo-Ichi Yamashita1, Rumi Itoyama1, Takanobu Yamao1, Naoki Umezaki1, Tatsunori Miyata1, Takaaki Higashi1, Kensuke Yamamura1, Shigeki Nakagawa1, Katsunori Imai1, Hiromitsu Hayashi1, Akira Chikamoto1, Hideo Baba1.   

Abstract

Patients with cholangiocarcinoma sometimes show very slow progression and thereby exhibit long-term survival under treatment of the disease. A 72-year-old male with hilar cholangiocarcinoma underwent extended-right hemi-hepatectomy and caudate lobectomy. Pathological finding revealed a well differentiated tumor and carcinoma in situ at the bile duct margin. Routine imaging follow-up was continued for 5 years. Ten years after the surgery, the patient noticed a right-hand chest wall mass formation of 5 cm without any symptoms, and the tumor was diagnosed metastatic cholangiocarcinoma by needle biopsy. Radical resection of the metastatic tumor was performed. The pathological findings of the primary tumor and the metastatic tumor were similar. Three months later, recurrent multiple lesions were identified in the chest wall and the liver. The patient received chemotherapy. We here report a rare case of metastatic cholangiocarcinoma 10 years after hepatectomy with positive ductal margin of carcinoma in situ, implying that rare event of very late recurrence of patients with hilar cholangiocarcinoma should be taken into consideration. © The Japan Society of Clinical Oncology 2020.

Entities:  

Keywords:  Chest wall metastasis; Hilar cholangiocarcinoma

Year:  2020        PMID: 32257758      PMCID: PMC7109235          DOI: 10.1007/s13691-020-00400-y

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  16 in total

1.  Hepatobiliary and Pancreatic: Skin metastases from cholangiocarcinoma mimicking herpes zoster.

Authors:  H Okabe; D Hashimoto; A Chikamoto; H Hayashi; H Nitta; K Taki; T Higashi; K Arima; T Ishiko; T Beppu; H Baba
Journal:  J Gastroenterol Hepatol       Date:  2015-09       Impact factor: 4.029

2.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Authors:  John N Primrose; Richard P Fox; Daniel H Palmer; Hassan Z Malik; Raj Prasad; Darius Mirza; Alan Anthony; Pippa Corrie; Stephen Falk; Meg Finch-Jones; Harpreet Wasan; Paul Ross; Lucy Wall; Jonathan Wadsley; Jeff T R Evans; Deborah Stocken; Raaj Praseedom; Yuk Ting Ma; Brian Davidson; John P Neoptolemos; Tim Iveson; James Raftery; Shihua Zhu; David Cunningham; O James Garden; Clive Stubbs; Juan W Valle; John Bridgewater
Journal:  Lancet Oncol       Date:  2019-03-25       Impact factor: 41.316

3.  Major hepatectomy for perihilar cholangiocarcinoma.

Authors:  Michiaki Unno; Yu Katayose; Toshiki Rikiyama; Hiroshi Yoshida; Kuniharu Yamamoto; Takanori Morikawa; Hiroki Hayashi; Fuyuhiko Motoi; Shinichi Egawa
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-11-26       Impact factor: 7.027

4.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

5.  Clinicopathologic study of cholangiocarcinoma with superficial spread.

Authors:  Tsuyoshi Igami; Masato Nagino; Koji Oda; Hideki Nishio; Tomoki Ebata; Yukihiro Yokoyama; Yoshie Shimoyama
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

6.  Abdominal wall recurrence of Hilar bile duct cancer 12 years after a curative resection: report of a case.

Authors:  Takafumi Machimoto; Ryuichiro Doi; Kohei Ogawa; Toshihiko Masui; Satoru Seo; Shinji Uemoto
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

7.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.

Authors:  Sung Gyu Lee; Gi Won Song; Shin Hwang; Tae Yong Ha; Deok Bog Moon; Dong Hwan Jung; Ki Hun Kim; Chul Soo Ahn; Myung Hwan Kim; Sung Koo Lee; Kyu Bo Sung; Gi Young Ko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-23       Impact factor: 7.027

8.  A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group.

Authors:  Shogo Kobayashi; Hiroaki Nagano; Akira Tomokuni; Kunihito Gotoh; Daisuke Sakai; Etsuro Hatano; Satoru Seo; Hiroaki Terajima; Yoichiro Uchida; Tetsuo Ajiki; Hironaga Satake; Keiko Kamei; Taiji Tohyama; Tetsuro Hirose; Iwao Ikai; Satoshi Morita; Tatsuya Ioka
Journal:  Ann Surg       Date:  2019-08       Impact factor: 12.969

9.  Anastomotic recurrence at hepaticojejunostomy in a long-term survivor of bile duct carcinoma: report of a case.

Authors:  N Tanaka; M Nobori; T Kohzuma; Y Suzuki; S Saiki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

10.  Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case.

Authors:  Yohei Ota; Ryusei Matsuyama; Koichi Taniguchi; Michio Ueda; Kazuhisa Takeda; Kuniya Tanaka; Takashi Nakayama; Itaru Endo
Journal:  Clin J Gastroenterol       Date:  2013-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.